Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ALNY - Alnylam Pharmaceuticals, Inc.
56.7 M
LAST VALUE
-18.61%
2 YEAR CAGR
0.83%
5 YEAR CAGR
16.87%
10 YEAR CAGR